Merck KGaA (MKKGY) Earnings Date, Estimates & Call Transcripts $26.33 +0.45 (+1.74%) As of 08/22/2025 03:55 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock Merck KGaA Earnings Summary Merck KGaA posted Q2 2025 earnings on August 7, 2025, reporting an EPS of $0.57, which beat the consensus estimate of $0.51 by $0.06. Quarterly revenue was reported to be $6.11 billion, above analyst estimates of $5.34 billion. With a trailing EPS of $2.38 and a P/E Ratio of 11.06, Merck KGaA's earnings are expected to grow 9.63% next year, from $1.87 to $2.05 per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportLatest Q2 2025 Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) $0.51 Actual EPS (Aug. 7) $0.57 Beat By $0.06 Actual Revenue (Aug. 7) $6.11B Get Merck KGaA Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMKKGY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MKKGY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Merck KGaA Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $1.87 EPSNext Year EPS Consensus Estimate $2.05 EPS Merck KGaA Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025$0.51$0.57+$0.06$0.57$5.34B$6.11B5/15/2025Q1 2025$0.50$0.59+$0.09$0.59$5.32B$5.89B3/6/2025Q4 2024$0.47$0.54+$0.07$0.54$5.40B$5.78B8/1/2024Q2 2024-$0.30-$0.30-$5.76B5/15/2024Q1 2024$0.38$0.35 -$0.03$0.35-$5.56B3/7/2024Q4 2023$0.43$0.40 -$0.03$0.51$5.58B$5.63B11/9/2023Q3 2023-$0.37-$0.37-$5.63B Merck KGaA Earnings - Frequently Asked Questions When did Merck KGaA announce their last quarterly earnings? Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on MKKGY's earnings history. Did Merck KGaA beat their earnings estimates last quarter? In the previous quarter, Merck KGaA (OTCMKTS:MKKGY) reported $0.57 earnings per share (EPS) to beat the analysts' consensus estimate of $0.51 by $0.06. Learn more on analysts' earnings estimate vs. MKKGY's actual earnings. How much revenue does Merck KGaA generate each year? Merck KGaA (OTCMKTS:MKKGY) has a recorded annual revenue of $22.57 billion. How much profit does Merck KGaA generate each year? Merck KGaA (OTCMKTS:MKKGY) has a recorded net income of $3.00 billion. MKKGY has generated $2.38 earnings per share over the last four quarters. What is Merck KGaA's price-to-earnings ratio? Merck KGaA (OTCMKTS:MKKGY) has a trailing price-to-earnings ratio of 11.06 and a forward price-to-earnings ratio of 14.08. The price/earnings-to-growth ratio is 3.24. What is Merck KGaA's EPS forecast for next year? Merck KGaA's earnings are expected to grow from $1.87 per share to $2.05 per share in the next year, which is a 9.63% increase. More Earnings Resources from MarketBeat Related Companies Zoetis Earnings Takeda Pharmaceutical Earnings Daiichi Sankyo Earnings BeOne Medicines Earnings Summit Therapeutics Earnings Shionogi & Co., Ltd. Unsponsored ADR Earnings United Therapeutics Earnings Neurocrine Biosciences Earnings Orion OYJ Earnings Madrigal Pharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (OTCMKTS:MKKGY) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access